PATENT CLAIM ANALYSIS

Application Number: 15873840
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["435", "007100"]

Abstract:
Provided herein are methods and devices for the detection of conditions or disorders by detecting altered levels of stress response pathway biomarkers. Also provided are methods and reagents for identifying panels of biomarkers associated with a condition or disorder.

Claim (Index 72):
The method of  claim 67 , wherein the treatment is selected from the group consisting of non-nucleosidase reverse transcriptase inhibitors, nucleosidase reverse transcriptase inhibitors, protease inhibitors, fusion inhibitors, CCR5 antagonists, integrase strand transfer inhibitors, diuretics, anti-seizure drugs, coma-inducing drugs, over the counter pain relievers, Antidepressants, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers, Beta blockers, Aldosterone antagonists, Inotropes, Digoxin, angiotensin receptor blockers (ARB), Physical therapy, speech therapy, recreation therapy, occupational therapy, vison therapy, counseling and/or a combination thereof.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 86.0
- Lexical Diversity: 1.28125
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15188822', '13122130', '14325252', '12282840', '13641009']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7439881707645355
- 35 USC 102 Novelty (BERT): 0.6748604616881412
- Combined Prediction Score: 0.7370753998568961
- Mean Citation Score: 561.5824200000002
- Max Citation Score: 929.56177
- Similarity Product: 658.8896331698704

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test